Elevated risk for AUD after COVID-19 infection observed in some time periods during the pandemic
Long-Term Sequelae Specific to SARS-CoV-2 Infection Identified
Palpitations, hair loss, fatigue, chest pain, dyspnea, joint pain, obesity seen after SARS-CoV-2 versus other viral respiratory infections
Practicing Physicians Saw Excess Mortality During COVID-19 Pandemic
However, physicians had substantially lower excess mortality than the general U.S. population
7th Cholera Pandemic Continues
The World Health Organization (WHO) today reported that the global cholera situation has further deteriorated, with at least 18 countries reporting cholera cases.
On February 11, 2023, the WHO assessed the health risk from these cholera outbreaks as very high globally.
The world is facing an acute upsurge of the 7th cholera pandemic characterized by the number, size, and concurrence of multiple outbreaks, the spread to areas free of cholera for decades, and alarming high mortality rates, says the WHO.
11 More Mammals Positive for Bird Flu
Since the avian influenza outbreak began in the U.S. in early 2022, millions of birds have been detected with Highly Pathogenic Avian Influenza (HAPI) influenza type A viruses.
The Eurasian H5N1 strain initially appeared in North America in January 2022 and has impacted 47 states, leading to the loss of over 58.3 million various types of birds as of February 11, 2023.
And this HAPI outbreak has crossed over into mammals.
11 More Mammals Positive for Bird Flu
Since the avian influenza outbreak began in the U.S. in early 2022, millions of birds have been detected with Highly Pathogenic Avian Influenza (HAPI) influenza type A viruses.
The Eurasian H5N1 strain initially appeared in North America in January 2022 and has impacted 47 states, leading to the loss of over 58.3 million various types of birds as of February 11, 2023.
And this HAPI outbreak has crossed over into mammals.
Will Georgia Score a Fungal Disease Vaccine
A recent HBO TV show has created extensive awareness that the U.S. Food and Drug Administration (FDA) has not approved a vaccine after decades of research to protect people from fungal diseases.
While invasive fungal infections cause over 1.5 million fatalities annually worldwide, they do not create 'zombies.'
However, researchers in Georgia are making progress with an experimental vaccine designed to protect against the three most common causes of fungal infections, Aspergillus, Candida, and Pneumocystis.
Fear of Needles Resolved with Pain-less Microarray Patch
A clinical-stage biotechnology company commercializing a novel vaccination platform announced a potential solution for millions afraid of needles.
This vaccine innovation is essential as researchers estimate that fear of needles affects up to 25% of adults and may lead to many people skipping standard vaccinations.
Vaxxas confirmed today it initiated a Phase I clinical trial with the first needle-free inactivated seasonal influenza vaccine quadrivalent (IIV4) candidate delivered using the Company's proprietary high-density microarray patch (HD-MAP) technology.
Fear of Needles Resolved with Pain-less Microarray Patch
A clinical-stage biotechnology company commercializing a novel vaccination platform announced a potential solution for millions afraid of needles.
This vaccine innovation is essential as researchers estimate that fear of needles affects up to 25% of adults and may lead to many people skipping standard vaccinations.
Vaxxas confirmed today it initiated a Phase I clinical trial with the first needle-free inactivated seasonal influenza vaccine quadrivalent (IIV4) candidate delivered using the Company's proprietary high-density microarray patch (HD-MAP) technology.
Suicide Rates Up for Most Race, Ethnic Groups in 2018 to 2021
Highest age-adjusted 2021 suicide rates and highest relative percentage change seen for American Indian or Alaska Native persons